Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy
- Status
- RECRUITING
- Phase
- N/A
Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Prognostic Value of Myosteatosis and Creatinine-to-cystatin C Ratio in Patients With Pancreatic Ductal Adenocarcinoma
- Status
- UNKNOWN
- Phase
- N/A
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
AMT-151 in Patients With Selected Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions
- Status
- COMPLETED
- Phase
- N/A
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)
- Status
- TERMINATED
- Phase
- PHASE1
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PHL Treatment in Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)
- Status
- RECRUITING
- Phase
- NA
A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1